MedTrace Logo

High Versus Low Dose Nitroglycerin in Acute Pulmonary Edema

NCT06107465 · Status: ENROLLING_BY_INVITATION · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-10-30

No results posted yet for this study

Summary

The goal of this randomized controlled trial is evaluate the out come of:

* Low dose (\< 100 mic/min )versus
* High dose (\> 100 mic/min) of nitroglycerin in management of patients with acute pulmonary edema presented to Emergency Department of Alexandria University Hospitals.

The main questions it aims to answer is:

* Time of resolution of high blood pressure, hypoxia, tacchypnea
* Need for invasive mechanical ventilation, ICU admission

Conditions

  • Pulmonary Edema

Interventions

DRUG

Nitroglycerin

high dose Nitroglycerin

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Abdelrahman Hemeda, Resident · Alexandria University, Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-10
Primary Completion
2024-06-30
Completion
2024-07-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06107465 on ClinicalTrials.gov